Early Breast Cancer Clinical Trials

ReadTheTrial indexes 3 studies for Early Breast Cancer. The most common development stage is Phase 3 (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Early Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 3
100%

Trial Status Breakdown

Trials for Early Breast Cancer

Optimal Personalized Treatment of Early Breast Cancer Using Multi-parameter Analysis: Focus on YOUNGer Women

NCT07106632 · NOT YET RECRUITING · Phase 3

A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)

NCT05827081 · RECRUITING · Phase 3

A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)

NCT03701334 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Early Breast Cancer?

There are 3 clinical trials listed for Early Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Early Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Early Breast Cancer trials in?

Current Early Breast Cancer trials are distributed across: Phase 3 (3).

Find More Trials